DUSLX
Price
$47.27
Change
-$0.11 (-0.23%)
Updated
Aug 11 closing price
Net Assets
4.58B
VIGAX
Price
$273.67
Change
-$1.74 (-0.63%)
Updated
Aug 11 closing price
Net Assets
371.99B
Interact to see
Advertisement

DUSLX vs VIGAX

DUSLX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
DUSLX vs. VIGAX commentary
Aug 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DUSLX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 372B vs. DUSLX (4.58B). DUSLX pays higher dividends than VIGAX: DUSLX (0.81) vs VIGAX (0.39). DUSLX was incepted earlier than VIGAX: DUSLX (14 years) vs VIGAX (26 years). DUSLX (0.18) is less costly to investors than VIGAX (0.05). VIGAX is a more actively managed with annual turnover of: 12.00 vs. DUSLX (10.00). DUSLX has a lower initial minimum investment than VIGAX: DUSLX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 16.86 vs. DUSLX (14.79). VIGAX return over 5 years is better than : 79.47 vs. DUSLX (54.53).
DUSLXVIGAXDUSLX / VIGAX
Total Expense Ratio0.180.05360%
Annual Report Gross Expense Ratio0.180.05360%
Fund Existence14 years26 years-
Gain YTD11.0229.664114%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.58B372B1%
Annual Yield % from dividends0.810.39210%
Returns for 1 year14.7916.8688%
Returns for 3 years65.5091.1472%
Returns for 5 years54.5379.4769%
Returns for 10 years220.07374.6659%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XBIO3.220.13
+4.21%
Xenetic Biosciences
OPRX6.920.06
+0.87%
OptimizeRx Corp
BLSH24.52-0.02
-0.08%
Bullish
MNPR114.46-1.89
-1.62%
Monopar Therapeutics Inc
HPQ29.07-0.73
-2.45%
HP